A new, chiral, and enantiomerically pure receptor has been prepared. The molecule binds to cyclohexanoid and alicyclic alkanes. Binding to stereoisomeric menthols, diastereomeric cyclohexane derivatives, and steroids has been studied. The use of the molecule as a chiral shift reagent is demonstrated.
No takes yet. Share an insight, caveat, or question.
Wilcox et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: